Clinical Trial

Medication Trial for Cervical Osmotic Dilators Placement

Study Description

Cervical Preparation With Mifepristone Prior to Osmotic Dilators

The investigators plan to study the role of mifepristone prior to the placement of cervical osmotic dilators to evaluate if the medication helps increase the number of dilators. This may help improve safety of dilation and evacuation (D&E) procedures.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - Mifepristone 200 MG

Ingestion of study medication vs placebo

Drug - Placebo Oral Tablet

Ingestion of study medication vs placebo

Additional Information

Official Study Title

Cervical Preparation With Mifepristone Prior to Osmotic Dilators: A Randomized, Double-blind, Placebo-controlled Pilot Study

Clinical Trial ID

NCT03714880

ParticipAid ID

av2jma